Novel Therapy of PAD by Combined Transplantation of BMCs
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00411840|
Recruitment Status : Unknown
Verified December 2006 by Heinrich-Heine University, Duesseldorf.
Recruitment status was: Recruiting
First Posted : December 15, 2006
Last Update Posted : December 15, 2006
We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.
After 2 and 13 months walking distance and perfusion indices were monitored.
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Arterial Disease||Procedure: intraarterial and intramuscular injection of BMCs||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Transplantation of Autologous Mononuclear Bone Marrow Stem Cells in Patients With Peripheral Arterial Disease (TAM-PAD Study)|
|Study Start Date :||July 2004|
- ABI, walking distance, capillary-venous oxygen saturation, venous occlusion plethysmography
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00411840
|Contact: Thomas Bartsch, MDfirstname.lastname@example.org|
|Duesseldorf, Germany, 40225|
|Contact: Bodo E Strauer, MD +492118118801 email@example.com|
|Principal Investigator: Thomas Bartsch, MD|
|Study Director:||Bodo E Strauer, MD||Heinrich-Heine University, Duesseldorf|